熱門資訊> 正文
LifeStance股东发起3500万股二次发行
2026-05-08 04:58
- LifeStance Health (Nasdaq: LFST) said on Thursday that certain shareholders plan to sell 35 million shares of the company’s common stock in a secondary public offering.
- The company said it would not sell any shares in the offering and would not receive any proceeds.
- The selling shareholders will receive all proceeds from the sale.
- LifeStance also said it had authorized the concurrent repurchase of 6 million shares from the underwriter, subject to completion of the offering.
- The repurchase price will match the price paid by the underwriter to the selling shareholders.
- Source: Press Release
More on LifeStance Health Group
- Lifestance forecasts $1.64B-$1.68B 2026 revenue while targeting mid-teens adjusted EBITDA margins by 2028
- LifeStance Health Group GAAP EPS of $0.04 beats by $0.03, revenue of $403.5M beats by $17.38M
推薦文章
騰訊、阿里等中概巨頭業績來襲！AI收入轉化率成關鍵，這輪財報季能否助力恆科「反彈」？
華盛早報 | 「完全不可接受」！特朗普拒絕伊朗方案，油價應聲漲逾3%；中美將於明日在韓舉行經貿磋商
港股周報 | 存儲芯片持續飆升！兩倍做多海力士周內狂漲64%；段永平重大調倉！清倉中國神華，大幅買入泡泡瑪特
一周財經日曆 | 下周重磅大事齊襲！特朗普政府或攜黃仁勛訪華；中概科網股財報季打響！騰訊、阿里同日放榜
美股機會日報 | 「TACO」已經過時？華爾街瘋狂湧入「NACHO」交易；今晚20:30！美國4月非農或創年內最大落差？
5月8日外盤頭條：美國計劃本周重啟護航行動 特朗普給予歐盟至7月4日批准貿易協議 OpenAI與博通芯片豪賭遇冷
CoreWeave一季度末簽約總電力容量3.5吉瓦 年內股價漲近80%
馬斯克再下注：SpaceX IPO倒計時 擬投1190億美元建Terafab芯片廠
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
